204 related articles for article (PubMed ID: 11721438)
1. The pathogenesis of dialysis-related amyloidosis: what's new?
Zhang X; Hou F
Chin Med J (Engl); 1999 Dec; 112(12):1059-62. PubMed ID: 11721438
[No Abstract] [Full Text] [Related]
2. [New amyloidosis disease associated with dialysis: accumulation of beta-2-microglobulin into joints and bones].
Kunelius P; Nurminen J; Kunelius R
Duodecim; 1990; 106(5):427-31. PubMed ID: 1670111
[No Abstract] [Full Text] [Related]
3. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
Gejyo F; Homma N; Arakawa M
Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
[TBL] [Abstract][Full Text] [Related]
4. Role of macrophages in beta 2-microglobulin-related dialysis amyloidosis.
Gejyo F; Maruyama H; Teramura T; Kazama J; Ei I; Arakawa M
Contrib Nephrol; 1995; 112():97-104. PubMed ID: 7554998
[No Abstract] [Full Text] [Related]
5. Dialysis related amyloidosis.
Bardin T
J Rheumatol; 1987 Aug; 14(4):647-9. PubMed ID: 3312600
[No Abstract] [Full Text] [Related]
6. Pathogenesis of dialysis-related amyloidosis.
Miyata T; Maeda K
Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):493-7. PubMed ID: 8591057
[TBL] [Abstract][Full Text] [Related]
7. Skeletal amyloidosis due to beta microglobulinemia in a patient on hemodialysis. A case report.
Hadjipavlou A; Lander P; Begin L; Bercovitch D; Davidman M; Jakab E
J Bone Joint Surg Am; 1988 Jan; 70(1):119-21. PubMed ID: 3275669
[No Abstract] [Full Text] [Related]
8. Beta 2-microglobulin-related amyloidosis: where do we stand?
Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
[No Abstract] [Full Text] [Related]
9. [Pathogenesis of dialysis amyloidosis].
Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
[No Abstract] [Full Text] [Related]
10. beta 2-microglobulin and amyloidosis: who is at risk?
Davison AM
Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
[No Abstract] [Full Text] [Related]
11. Prevalence of HLA-B27 antigens in patients with dialysis-related beta 2-M amyloidosis.
Charmes JP; Drouet M; Leroux-Robert C; Ton That H; Bouteiller G
Clin Nephrol; 1991 Oct; 36(4):214. PubMed ID: 1959251
[No Abstract] [Full Text] [Related]
12. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
Higuchi N; Maruyama H
Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
Kopeć J
Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
[TBL] [Abstract][Full Text] [Related]
14. A beta 2m amyloidosis.
Di Raimondo CR; Stone WJ
Int J Artif Organs; 1987 Sep; 10(5):281-3. PubMed ID: 3316047
[No Abstract] [Full Text] [Related]
15. Clinical aspects of dialysis-related amyloidosis.
Schäffer J; Floege J; Koch KM
Contrib Nephrol; 1995; 112():90-6. PubMed ID: 7554997
[No Abstract] [Full Text] [Related]
16. Dialysis amyloidosis.
Lancet; 1991 Aug; 338(8763):349-50. PubMed ID: 1677703
[No Abstract] [Full Text] [Related]
17. Beta 2-microglobulin amyloidosis.
Saito A
Nephrol Dial Transplant; 1994; 9 Suppl 2():116-9. PubMed ID: 8065602
[No Abstract] [Full Text] [Related]
18. [Contribution of Japanese researchers to progress in studies on nephrology in the past 100 years: Beta2-microglobulin as an etiological factor of amyloidosis in patients undergoing hemodialysis].
Gejo F
Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1434-6. PubMed ID: 12082730
[No Abstract] [Full Text] [Related]
19. Dialysis amyloidosis: clinical aspects and therapeutic approach.
Brancaccio D; Cozzolino M; Gallieni M
Nephrol Dial Transplant; 1996; 11 Suppl 3():102-5. PubMed ID: 8840323
[No Abstract] [Full Text] [Related]
20. New type of amyloidosis. a). beta 2-Microglobulin and hemodialysis.
Gejyo F; Arakawa M
Intern Med; 1993 Dec; 32(12):925-7. PubMed ID: 8204972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
